Published in Health Insurance Week, September 3rd, 2006
The two companies envisage accelerating the development and commercialization of low-cost, easy-to-use and readily portable Point-of-Care (POC) diagnostic devices. Initial devices will enable personalized on-the-spot monitoring for diabetes management and diagnosis of STDs (Sexually Transmitted Diseases), cardiovascular diseases and substances of abuse, based on the unique BioLED technology platform.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.